Skip to main content

Table 2 Impact of Diabetic-related Co-morbid Conditions on Treatment Satisfaction

From: Examining correlates of treatment satisfaction for injectable insulin in type 2 diabetes: lessons learned from a clinical trial comparing biphasic and basal analogues

 

ITSQ Overall (n = 197)

ITSQ IR (n = 196)

ITSQ LF (n = 196)

ITSQ HC (n = 197)

ITSQ GC (n = 197)

ITSQ DD (n = 197)

 

Coefficient (t-ratio)

Intercept

84.11*** (56.89)

87.24*** (51.36)

78.85*** (41.72)

81.75*** (42.67)

86.43*** (49.64)

84.79*** (54.58)

Retinopathy (N = 0, Y = 1)

7.29 (1.50)

8.94 (1.60)

0.95 (0.15)

2.31 (0.37)

10.17 (1.78)

10.90* (2.13)

Nephropathy (N = 0, Y = 1)

2.08 (0.40)

-0.61 (-0.10)

3.68 (0.55)

3.79 (0.56)

-2.57 (-0.42)

3.94 (0.71)

Neuropathy (N = 0, Y = 1)

-10.56*** (-3.53)

-8.81* (-2.54)

-12.42** (-3.22)

-10.80** (-2.79)

-13.43*** (-3.82)

-8.00* (-2.54)

Macro Angiopathy (N = 0, Y = 1)

-5.18 (-1.09)

-1.16 (-0.21)

-4.58 (-0.76)

-5.63 (-0.92)

-5.93 (-1.06)

-6.44 (-1.29)

 

F = 3.622**

F = 1.888

F = 2.943*

F = 2.280

F = 4.281**

F = 2.789*

 

R2 = 0.069

R2 = 0.037

R2 = 0.057

R2 = 0.044

R2 = 0.080

R2 = 0.054

 

Adj R2 = 0.050

Adj R2 = -0.018

Adj R2 = 0.038

Adj R2 = 0.025

Adj R2 = 0.062

Adj R2 = -0.035

  1. • * p < 0.05, ** p < 0.01, *** p < 0.001
  2. • IR = Inconvenience of Regime subscale, LF = Lifestyle Flexibility subscale, HC = Hypoglycemic Control subscale, GC = Glycemic Control subscale, DD = Device Delivery subscale